Warner & Webster is actively monitoring the availability of several Rapid Antingen Testing products in Australia, as the arrival of the Omicron Variant in the lead up to the Christmas-New Year period has significantly increased demand for these products.
We are working closely with suppliers to fill orders as quickly as possible, however the rapid surge in demand has meant that certain products are no longer available.
Warner & Webster are not accepting backorders at this time, and we apologise for any inconvienience this may cause.
Please note: Due to TGA restrictions, we are unable to supply the products below direct to consumers.
Click here for Rapid Antigen Self-Tests approved for use by the general public.
The COVID-19 Rapid Antigen Test is not a substitute for a PCR test, Rapid Antigen testing is only for screening purposes and you should rely on a PCR test if unwell at all.
This test is only a screening aid in detecting antigen from the SARS-CoV-2 virus in individuals suspected of COVID-19.
This product is strictly intended for professional use in laboratory and Point of Care environment.
What is the difference between nasal and nasypharyngeal tests?
The COVID-19 Rapid Antigen Test Nasal provides rapid results for fast decision making at the Point of Care. Nasal sampling is less invasive, which can reduce patient discomfort, and minimize the duration of the procedure as well as the risk of sneezing or coughing. Nasal swab samples may be self-collected by patients under supervision, offering further protection for healthcare professionals.
Rapid Antigen tests do not replace PCR tests, you should always consult your medical professional and get a PCR test if unwell.
The value of rapid testing is that they can detect an active infection before symptoms become apparent, especially when used regularly as part of a testing regime, while the patient is shedding high levels of the virus and therefore has a high risk of transmitting it to others.
Rapid Antigen tests do not replace PCR tests, you should always consult your medical professional and get a PCR test if unwell.
The tests can be supplied for use by specified health practitioners at the point of care to the following:
The tests can also be supplied to accredited laboratories and to Commonwealth, state or territory government departments, in cooperation with their relevant health departments.
In South Australia, Point of care antigen based or nucleic acid based tests for detecting or diagnosing COVID-19 may be used by:
In Western Australia, the Chief Health Officer has revoked the directions prohibiting the use of Rapid Antigen Tests as of 10 January 2022.
PanbioTM COVID-19 Ag Live Action Demo Video
If you are after 1,000 or more tests please give us a call on 1300 556 917
Product Code | Product Description | Test Type | UoM | Brand |
225139 | COVID-19 Rapid Antigen Test Panbio 25s | Nasopharyngeal | Box/25 | Abbott |
225167 | COVID-19 Rapid Antigent Test OnSite 20s | Nasopharyngeal | Box/20 | OnSite |
General Information from the Therapeutic Goods Administration
Abbott Panbio Tests
OnSite Tests